Security key
61023L207
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,578,295
- Total 13F value
- $57,125,546
- Share change
- +2,562,488
- SEC-reported price per share
- $22.00
- Number of holders
- 18
- Value change
- +$56,777,792
- Number of buys
- 14
- Number of sells
- 1
- Shares outstanding
- 6,646,654
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
18
Top holders
10
MNPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Monopar Therapeutics SEC filings
Monopar Therapeutics company facts
Monopar Therapeutics 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 61023L207
Recent filing periods:
Ownership snapshot
Top reported holders of MNPR - Monopar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
Michael J. Brown
Comparable rows
6/10
Latest evidence
28 Oct 2024
13F
3/4/5
Lead comparable stake: 0.21%
4 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 0.21%.
6 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GEODE CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
GEODE CAPITAL MANAGEMENT, LLC
0.21%
NewEdge Advisors, LLC
0.01%
UBS Group AG
0.01%
WELLS FARGO & COMPANY/MN
0.01%
Federation Des Caisses Desjardins...
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.21%
|
$94,804
14,066 shares
|
— | 30 Sep 2024 |
| NewEdge Advisors, LLC |
13F
Company
|
0.01%
|
$4,044
600 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.01%
|
$3,451
512 shares
|
— | 30 Sep 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.01%
|
$3,370
500 shares
|
— | 30 Sep 2024 |
| Federation Des Caisses Desjardins du Quebec |
13F
Individual
|
0%
|
$108
16 shares
|
— | 30 Sep 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$88
13 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
2,578,295
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
6
Q4 2024 holders
18
Holder diff
12
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend